ScoreWhy is Amedisys, Inc. ?
1
High Management Efficiency with a high ROCE of 16.15%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.20 times
3
Poor long term growth as Operating profit has grown by an annual rate 3.79% of over the last 5 years
4
Positive results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD 238.92 MM
- NET PROFIT(HY) At USD 116.79 MM has Grown at 77.89%
- DEBT-EQUITY RATIO (HY) Lowest at 9.18 %
5
With ROCE of 16.58%, it has a expensive valuation with a 2.80 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.58%, its profits have risen by 65.7% ; the PEG ratio of the company is 0.3
6
Underperformed the market in the last 1 year
- The stock has generated a return of 2.58% in the last 1 year, much lower than market (S&P 500) returns of 19.11%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Amedisys, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Amedisys, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Amedisys, Inc.
2.58%
0.85
12.30%
S&P 500
13.22%
0.96
19.87%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.03%
EBIT Growth (5y)
5.78%
EBIT to Interest (avg)
12.61
Debt to EBITDA (avg)
1.20
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
1.51
Tax Ratio
43.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
16.15%
ROE (avg)
16.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.97
EV to EBIT
16.88
EV to EBITDA
15.03
EV to Capital Employed
2.80
EV to Sales
1.55
PEG Ratio
0.30
Dividend Yield
NA
ROCE (Latest)
16.58%
ROE (Latest)
15.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 238.92 MM
NET PROFIT(HY)
At USD 116.79 MM has Grown at 77.89%
DEBT-EQUITY RATIO
(HY)
Lowest at 9.18 %
INTEREST COVERAGE RATIO(Q)
Highest at 1,238.33
RAW MATERIAL COST(Y)
Fallen by -100.47% (YoY
CASH AND EQV(HY)
Highest at USD 622.18 MM
NET SALES(Q)
Highest at USD 621.86 MM
OPERATING PROFIT(Q)
Highest at USD 79.44 MM
OPERATING PROFIT MARGIN(Q)
Highest at 12.77 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Amedisys, Inc.
Interest Coverage Ratio
Highest at 1,238.33
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Profit
At USD 116.79 MM has Grown at 77.89%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at 9.18 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at USD 238.92 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 621.86 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 79.44 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 12.77 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Cash and Eqv
Highest at USD 622.18 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -100.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
